Selected article for: "abnormal lymphocyte count and lymphocyte count"
Author: meizhu chen; changli tu; Cuiyan Tan; Xiaobin Zheng; xiaohua wang; jian wu; Yiying Huang; zhenguo wang; yan yan; zhonghe li; hong shan; Jing Liu; jin huang
Title: Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression
  • Document date: 2020_4_11
    • ID: 97gawzw4_25
    Snippet: Hemoptysis, dyspnea, hyperbilirubinemia, high α-HBDH and high LDH were more common in severe and critical stage than in mild stage (P<0.05). Lymphocyte count, CRP, D-dimer, BNP, and Albumin were generally abnormal in the course of COVID-19 patients, and the abnormal changes were more significant with the aggravation of the disease. (P<0.05).The deterioration of the above indicators indicated that the patient's condition was rapid progress, which.....
    Document: Hemoptysis, dyspnea, hyperbilirubinemia, high α-HBDH and high LDH were more common in severe and critical stage than in mild stage (P<0.05). Lymphocyte count, CRP, D-dimer, BNP, and Albumin were generally abnormal in the course of COVID-19 patients, and the abnormal changes were more significant with the aggravation of the disease. (P<0.05).The deterioration of the above indicators indicated that the patient's condition was rapid progress, which required close monitoring and early intervention.

    Search related documents:
    Co phrase search for related documents
    • close monitoring and early intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • close monitoring and early intervention close monitoring: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • close monitoring and early intervention close monitoring require: 1
    • close monitoring and Lymphocyte count: 1, 2, 3, 4, 5, 6, 7
    • close monitoring and patient condition: 1, 2
    • close monitoring and patient course: 1
    • close monitoring and rapid progress: 1
    • critical severe stage and disease aggravation: 1, 2
    • critical severe stage and Lymphocyte count: 1, 2, 3
    • critical severe stage and mild stage: 1, 2, 3, 4, 5, 6
    • critical severe stage and rapid progress: 1
    • disease aggravation and early intervention: 1, 2, 3, 4, 5
    • disease aggravation and Lymphocyte count: 1, 2, 3, 4, 5, 6, 7
    • disease aggravation and mild stage: 1
    • disease aggravation and patient condition: 1
    • early intervention and Lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • early intervention and mild stage: 1, 2, 3, 4
    • early intervention and patient condition: 1, 2, 3, 4, 5, 6
    • early intervention and rapid progress: 1